AI Articles and Analysis in Healthcare

It should come as no surprise that AI has found its way into radiology in a similar fashion to most other medical fields. Many AI vendors selling into the radiology field are just beginning to gain regulatory approval. We researched the use of AI in radiology to better understand where AI comes into play in the industry and to answer the following questions:

International Data Corporation reports that the global wearables market continued to grow in the second quarter of 2018 as shipments reached 27.9 million units, an increase of 5.5% year-on-year. This growth translated to $4.8 billion year-on-year for the quarter. Smartwatches continued to be the most popular wearables.

Several factors have contributed to the advancement of AI in the pharmaceutical industry. These factors include the increase in the size of and the greater variety of types of biomedical datasets, as a result of the increased usage of electronic health records.

The clinical trial is a foundational pillar of the pharmaceutical drug discovery process. Essentially, clinical trials are research studies which seek to determine if a medical treatment or device is safe and effective for humans. While the pharmaceutical drug industry has experienced some fluctuations it remains a profitable market. Global prescription drug expenditures are estimated to reach nearly $1.5 trillion by 2021 according to Quintiles IMS Holding.  

Before getting into this report, we have to inform readers that none of the companies discussed below claim to offer software that provides diagnostics, except Cognoa, which has FDA approval to call itself a diagnostic tool. We suspect this is because these companies are not legally allowed to do so. We usually don't refer to a dictionary to determine what constitutes a concept, preferring to create our own informed definitions, such as in our What is Machine Learning? piece, but Merriam Webster defines "diagnosis" as the following: "the art or act of identifying a disease from its signs and symptoms."

The healthcare domain seems ripe for disruption by way of artificial intelligence in the form of predictive analytics. Accenture estimates the AI in healthcare market will reach $6.6 billion by 2021.

Episode Summary: This week on AI in Industry, we speak with Amir Saffari, Senior Vice President of AI at BenevolentAI, a London-based pharmaceutical company that uses machine learning to find new uses for existing drugs and new treatments for diseases.

Gesture-based interfaces are applications that allow users to control devices using hand and other body parts. Today, they are found in devices used in home automation, shopping, consumer electronics, virtual reality and augmented reality gaming, navigation, and driving, among others.